 BOTHELL, Wash., Jan. 12, 2021 GLOBE NEWSWIRE -- Cocrystal Pharma, Inc. Nasdaq: COCP, Cocrystal or the Company, a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics, announces that management will present at NobleCon17, Noble Capital Markets 17th Annual Investor Conference on Tuesday, January 19, 2021 at 2:15 p.m. Eastern time 11:15 a.m. Pacific time. 